SIM
SRNE

Sonora Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Sonora Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-61,804
Closed -$689K – 1805
2020
Q3 		$689K Buy
+61,804
New +$566K 0.06% 181

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sonora Investment Management's SRNE Position: Q4 2020 in Review

Sonora Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2020, closing a stake of 61,804 shares — an estimated $689K sold.

Sonora Investment Management first reported a position in SRNE in Q3 2020 and held it in 1 quarter. The position peaked at $689K in Q3 2020. 219 funds tracked by Wall St. Rank hold SRNE as of Q4 2020.

  • Sonora Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Sonora Investment Management sold 61,804 Sorrento Therapeutics, Inc. shares in Q4 2020, an estimated $689K.
  • Sonora Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q3 2020 and held it in 1 quarter.
  • Sonora Investment Management's Sorrento Therapeutics, Inc. position peaked at $689K in Q3 2020.
  • 219 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2020.

Based on Sonora Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.